17-DMAG (alvespimycin)

alvespimycin · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 17-DMAG (alvespimycin), covering 2013-01-25 to 2013-01-25. Get the full timeline:

Most recent: Clinical Trial Update: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [Phase 1]